Marine Fidelle

9PUBLICATIONS
125CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

|Jan 28, 2026
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.

Sreya Duttagupta, Meriem Messaoudene, Sebastian Hunter

|Jan 07, 2026
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma.

Carolina Alves Costa Silva, Marc Machaalani, Renee Maria Saliby

|Jul 04, 2025
Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer.

Léa Montégut, Adrien Rousseau, Cinzia Ungolo

|Jun 11, 2025
Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency.

Laura Marcos-Kovandzic, Michele Avagliano, Myriam Ben Khelil

|Feb 23, 2024
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial.

Carolina Alves Costa Silva, Gianmarco Piccinno, Déborah Suissa

Pageof 2

Frequent Collaborators

8 joint publications

Laurence Zitvogel

6 joint publications

Guido Kroemer

6 joint publications

Bertrand Routy

6 joint publications

Nicola Segata